Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Relmada Therapeutics
RLMD
$562M
| $126K | ﹤0.01% |
55,568
-5,065
| -8% | -$17.5K |
|
|
PPTA
3277
Perpetua Resources
PPTA
$2.37B
| $124K | ﹤0.01% |
27,910
| – | – |
|
3278
Sypris Solutions
SYPR
$44.2M
| $124K | ﹤0.01% |
63,086
-11,784
| -16% | -$23.3K |
|
3279
BioAtla
BCAB
$5.61M
| $123K | ﹤0.01% |
920
+20
| +2% | +$3.6K |
|
|
TBLT
3280
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
| $120K | ﹤0.01% |
1,555
+1,321
| +565% | +$162K |
|
3281
Astrotech Corp
ASTC
$12.6M
| $120K | ﹤0.01% |
11,276
| – | – |
|
3282
Turkcell
TKC
$4.72B
| $120K | ﹤0.01% |
27,847
+3,016
| +12% | +$13.8K |
|
3283
Franklin Wireless
FKWL
$27.3M
| $117K | ﹤0.01% |
23,495
+12,702
| +118% | +$63.2K |
|
|
AEY
3284
DELISTED
ADDvantage Technologies Group
AEY
| $115K | ﹤0.01% |
10,404
-132
| -1% | -$1.86K |
|
|
OMGA
3285
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $115K | ﹤0.01% |
19,126
| – | – |
|
|
NVNO
3286
enVVeno Medical
NVNO
$7.09M
| $114K | ﹤0.01% |
686
+72
| +12% | +$13.5K |
|
3287
Applied Optoelectronics
AAOI
$7.23B
| $114K | ﹤0.01% |
51,364
-8,189
| -14% | -$20.1K |
|
3288
Veritone
VERI
$97.6M
| $112K | ﹤0.01% |
19,232
+991
| +5% | +$6.82K |
|
|
UBX
3289
DELISTED
Unity Biotechnology
UBX
| $111K | ﹤0.01% |
67,899
+37,473
| +123% | +$150K |
|
3290
Verrica Pharmaceuticals
VRCA
$90.4M
| $110K | ﹤0.01% |
+1,697
| New | +$103K |
|
3291
AC Immune
ACIU
$241M
| $108K | ﹤0.01% |
+46,247
| New | +$107K |
|
3292
Nortech Systems
NSYS
$37.7M
| $108K | ﹤0.01% |
10,138
+28
| +0.3% | +$375 |
|
|
BLPH
3293
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $107K | ﹤0.01% |
+13,585
| New | +$47.3K |
|
3294
AYTU BioPharma
AYTU
$23.1M
| $106K | ﹤0.01% |
+47,263
| New | +$138K |
|
|
DBTX
3295
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $105K | ﹤0.01% |
34,607
| – | – |
|
3296
Clover Health Investments
CLOV
$2.29B
| $104K | ﹤0.01% |
122,739
-50,446
| -29% | -$55.2K |
|
3297
Lyell Immunopharma
LYEL
$336M
| $101K | ﹤0.01% |
2,137
-4,593
| -68% | -$246K |
|
3298
Motorsport Games
MSGM
$19M
| $101K | ﹤0.01% |
+17,678
| New | +$158K |
|
|
CARM
3299
DELISTED
Carisma Therapeutics
CARM
| $101K | ﹤0.01% |
+32,448
| New | +$309K |
|
3300
INNOVATE Corp
VATE
$111M
| $101K | ﹤0.01% |
+3,385
| New | +$98.9K |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.